Del Monte Corporation is rated a Strong Buy due to its undervaluation and strong margin of safety, even though 2026 is expected to be challenging. The company's recent acquisition of Del Monte Foods and expansion into value-added product segments are improving margins and setting up a rebound in 2027. Key growth drivers include working capital normalization, recovery in the banana segment, and entry into the China market, which should boost free cash flow. Del Monte's solid balance sheet and competitive position against private label threats support significant upside potential from current levels.
Del Monte's outlook for 2027 is highlighted here with Pluang's Consumer Staples sector data as context. As of Oct 29, 2026 20:03 WIB, out of 63 priced US Consumer Staples stocks on Pluang, 50 rose and 11 fell. Notable movers include General Mills, Inc. (GIS) at USD 33.67 with a 1-day change of +1.88% and Pluang order activity showing 82% Sell / 18% Buy, and McCormick & Company, Incorporated (MKC) at USD 46.90 with a 1-day change of +1.82%.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
